China Digest: Biopharma startup Alebund raises $60m; Revere VC closes seed round
China Digest: Biopharma startup Alebund raises $60m; Revere VC closes seed round May 11, 2021 Chinese biopharmaceutical startup Alebund Pharmaceuticals has secured $60 million in a Series B round, while San Francisco and Hong Kong-based asset management firm Revere VC has closed its seed round. Alebund Pharma nets $60m in Series B round Alebund Pharmaceuticals, a biopharmaceutical startup that develops innovative therapies for the treatment of renal diseases, has bagged $60 million in a Series B round of financing, the startup announced on May 9. The Series B round was led by Quan Capital, a...
Source: dealstreetasia.com